Ir Complexes Research Articles

Bithiophene-Functionalized Infrared Two-Photon Absorption Metal Complexes as Single-Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy.

A planar conjugated ligand functionalized with bithiophene and its Ru(II), Os(II), and Ir(III) complexes have been constructed as single-molecule platform for synergistic photodynamic, photothermal, and chemotherapy. The complexes have significant two-photon absorption at 808 nm and remarkable singlet oxygen and superoxide anion production in aqueous solution and cells when exposed to 808 nm infrared irradiation. The most potent Ru(II) complex Ru7 enters tumor cells via the rare macropinocytosis, locates in both nuclei and mitochondria, and regulates DNA-related chemotherapeutic mechanisms intranuclearly including DNA topoisomerase and RNA polymerase inhibition and their synergistic effects with photoactivated apoptosis, ferroptosis and DNA cleavage. Ru7 exhibits high efficacy in vivo for malignant melanoma and cisplatin-resistant non-small cell lung cancer tumors, with a 100 % survival rate of mice, low toxicity to normal cells and low residual rate. Such an infrared two-photon activatable metal complex may contribute to a new generation of single-molecule-based integrated diagnosis and treatment platform to address drug resistance in clinical practice and phototherapy for large, deeply located solid tumors.

Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis

The development of anticancer drugs to treat triple-negative breast cancer (TNBC) is an ongoing challenge. Immunogenic cell death (ICD) has garnered considerable interest worldwide as a promising synergistic modality for cancer chemoimmunotherapy. However, only few drugs or treatment modalities can trigger an ICD response and none of them exert a considerable clinical effect against TNBC. Therefore, new agents with potentially effective chemoimmunotherapeutic response are required. In this study, five new cyclometalated Ir(III) complexes containing isoquinoline alkaloid CˆN ligands were designed and synthesized. Among them, Ir-1 exhibited the highest in vitro cytotoxicity. Mechanistically, Ir-1 could trigger autophagy-dependent ferroptosis and a subsequent ferroptosis-dependent ICD response as well as indoleamine 2,3-dioxygenase (IDO) inhibition via reactive oxygen species (ROS)-mediated endoplasmic reticulum (ER) stress in MDA-MB-231 cells. When immunocompetent BALB/c mice were vaccinated with Ir-1-treated dying TNBC cells, antitumor CD8+ T-cell response and Foxp3+ T-cell depletion were induced, resulting in long-lasting antitumor immunity in TNBC cells. Moreover, combination therapy with Ir-1 and anti-PD1 could substantially augment in vivo therapeutic effects. Based on these results, Ir-1 is a promising candidate for chemoimmunotherapy against TNBC and its effects are mediated synergistically via ICD induction and IDO blockage.

Template Synthesis of Cyclometalated Macrocycle Iridium(III) Complexes Based on Photoinduced C-N Cross-Coupling Reactions In Situ.

The synthesis of metal macrocycle complexes holds paramount importance in coordination and supramolecular chemistry. Toward this end, we report a new, mild, and efficient protocol for the synthesis of cyclometalated macrocycle Ir(III) complexes: [Ir(L1)](PF6) (1), [Ir(L2)](PF6) (2), and [Ir(L3)](PF6) (3), where L1 presents 10,17-dioxa-3,6-diaza-2(2,8),7(8,2)-diquinolina-1,8(1,4)-dibenzenacyclooctadecaphane, L2 is 10,13,16,19,22,25-hexaoxa-3,6-diaza-2(2,8),7(8,2)-diquinolina-1,8(1,4)-dibenzenacyclohexacosaphane, and L3 is 4-methyl-10,13,16,19,22,25-hexaoxa-3,6-diaza-2(2,8),7(8,2)-diquinolina-1,8(1,4)-dibenzenacyclohexacosaphane. This synthesis involves the preassembly of two symmetric 2-phenylquinoline arms into C-shape complexes, followed by cyclization with diamine via in situ interligand C-N cross-coupling, employing a metal ion as a template. Moreover, the synthetic yield of these cyclometalated Ir(III) complexes, tethered by an 18-crown-6 ether-like chain, is significantly enhanced in the presence of K+ ion as a template. The resultant cyclometalated macrocycle Ir(III) complexes exhibit high stability, efficient singlet oxygen generation, and superior catalytic activity for the aerobic selective oxidation of sulfides into sulfoxides under visible light irradiation in aqueous media at room temperature. The photocatalyst 2 demonstrates recyclability and can be reused at least 10 times without a significant loss of catalytic activity. These results unveil a new and complementary approach to the design and in situ synthesis of cyclometalated macrocycle Ir(III) complexes via a mild interligand-coupling strategy.

Investigating episodic mass loss in evolved massive stars

Context. Episodic mass-loss events such as giant eruptions in luminous blue variables or pre-supernova eruptions in red supergiants drastically alter the evolutionary path of a massive star, resulting in a rich and complex circumstellar environment and IR excess. However, the incidence of these events, and hence their importance in massive star evolution, remains unknown. Aims. The ASSESS project (Episodic Mass Loss in Evolved Massive Stars: Key to Understanding the Explosive early Universe) aims to determine the role of episodic mass loss in the evolution of massive stars. As a first step, we constructed a catalog of spectroscopically identified dusty, evolved massive stars in ten southern galaxies for which Spitzer point-source catalogs are available. The resulting catalog may be used to identify stars that have undergone an episodic mass-loss event. The target galaxies span a range of metallicities, Z = 0.06–1.6 Z⊙, allowing for the investigation of a potential metallicity dependence. Methods. We conducted multi-object spectroscopy of dusty massive star candidates in ten target galaxies using the Very Large Telescope. We obtained 763 spectra from WLM, NGC 55, NGC 247, NGC 253, NGC 300, NGC 1313, NGC 3109, Sextans A, M83, and NGC 7793. The targets were selected using their Spitzer photometry, by prioritizing targets with a strong IR excess, which indicates the presence of hot dust. We determined a spectral classification for each target. Additionally, we used archival images from the Hubble Space Telescope (HST), available for 150 of our targets, to provide a visual classification for 80 targets, as a star, cluster, or galaxy. Results. We provide a catalog of 541 spectroscopically classified sources that includes 185 massive stars, of which 154 are newly classified massive stars. The catalog contains 129 red supergiants, 27 blue supergiants, 10 yellow supergiants, 4 luminous blue variable candidates, 7 supergiant B[e] stars, and 8 emission-line objects. Evidence for circumstellar dust is found in 24% of these massive stars, based on their IR colors. We report a success rate of 28% for identifying massive stars from our observed spectra, while the average success rate of our priority system for selecting evolved massive stars is 36%. Additionally, the catalog contains 21 background galaxies (including active galactic nuclei and quasars), 10 carbon stars, and 99 H II regions. We measured the line ratios [N II]/Hα and [S II]/Hα for 76 H II regions and 36 other spectra with nebular emission lines, thereby identifying eight sources with shocked emission. Conclusions. We present the largest catalog of evolved massive stars and in particular of red supergiants in nearby galaxies at low Z beyond the Local Group. The brightest and reddest of these are candidates for episodic mass loss. The fraction of dusty massive stars observed with respect to the initial selection is ~30%. We expect this catalog to trigger follow-up studies and pave the way for a comprehensive study of the eruptive late stages of massive star evolution in the era of the James Webb Space Telescope and the new survey telescopes (e.g., the Euclid mission, Nancy Grace Roman Space Telescope, and Vera C. Rubin Observatory).

Redox-Active Triazole-Derived Mesoionic Imines with Ferrocenyl Substituents and their Metal Complexes: Directed Hydrogen-Bonding, Unusual C-H Activation and Ion-Pair Formation.

We present herein the synthesis, characterization and complexation of ferrocenyl-substituted MIIs (mesoionic imines) and their metal complexes. In the free MIIs, strong hydrogen bonding interactions are observed between the imine-N and the C-H bonds of the ferrocenyl substituents both in the solid state and in solution. The influence of this hydrogen bonding is so strong that complexation of the MIIs with [IrCp*Cl2]2 yields unique six-membered iridacycles via C-H-activation of the corresponding C-H-site at the Fc-substituent and not the Ph-substituent. This result is in contrast to previous reports in which always a preferential C-H activation at the phenyl substituent is observed in competitive reactions in the presence of ferrocenyl substituents. The corresponding Ir complexes formed after in-situ halide exchange reaction exist in either [Ir-I] contact or as [Ir]+I- solvent separated ion-pairs depending on the solvent polarity. The iodide coordinated and solvent separated ion-pairs display drastically different physical properties. The TEP (Tolman-electronic-parameter) of these ligands was determined and lines up with previously reported MII-ligands. The redox properties were investigated by a combination of electrochemical and spectroelectrochemical methods. We show here how non-covalent interactions can have a drastic influence on the physical and chemical properties of these new class of compounds.

Lanthanide-Sensitized Upconversion Iridium Complex via Triplet Energy Transfer.

Cyclometalated iridium (Ir) complexes demonstrate impressive capabilities across a range of fields, including biology and photocatalysis, due to their tunable optical characteristics and structure flexibility. However, generating upconversion luminescence of Ir complexes under near-infrared light excitation is challenging. Herein, by employing lanthanide-doped upconversion nanoparticles (UCNPs) as the sensitizer, a new strategy is demonstrated to gain upconversion luminescence of Ir complexes via triplet energy transfer. This design relies on a rationally designed hybrid of core-shell structured NaYbF4:Tb@NaTbF4 UCNPs and new Ir phosphonate complexes, in which UCNPs can migrate upconverted energy to the surface of nanoparticles through Tb3+-mediated energy migration and then sensitize the upconversion luminescence of Ir complexes upon 980nm excitation. Both experimental and theoretical investigations highlight the significance of triplet energy transfer from excited Tb3+ ions to the triplet state of Ir complexes in the sensitization of upconversion luminescence of Ir complexes. These findings may open exciting avenues for fabricating hybrid Ir materials with new functions and driving the development of UCNP-based nanomaterials.

Application of Mono and Trinuclear Cyclometalated Iridium (III) Complexes in Differential Bacterial Imaging and Antimicrobial Photodynamic Therapy.

The application of transition metal complexes for antimicrobial photodynamic therapy (PDT) has emerged as an attractive alternative in mitigating a broad range of bacterial pathogens, including multidrug-resistant pathogens. In view of their photostability, long excited-state lifetimes, and tunable emission properties, transition metal complexes also contribute as bioimaging agents. In the present work, we designed mono and trinuclear cyclometalated iridium (III) complexes to explore their imaging application and antibacterial potential. For this, we used Methicillin-resistant S. aureus (MRSA), the most prevalent of community-associated (CA) multidrug-resistant (MDR) bacteria (CA MDR) and Lactococcus lactis (L. lactis) as Gram-positive while Campylobacter jejuni (C. jejuni) and E. coli as Gram-negative bacteria. In addition to differential bioimaging of these bacteria, we assessed the antibacterial effects of both mono and trinuclear Ir(III) complexes under exposure to 427 nm LED light. The data presented herein strongly suggest better efficacy of trinuclear Ir(III) complex over the mononuclear complex in imparting photoinduced cell death of MRSA. Based on the safety profile of these complexes, we propose that trinuclear cyclometalated iridium(III) complex holds great promise for selective recognition and targeting MDR bacteria with minimal off-target effect.

Synthesis, X-ray Studies and Photophysical Properties of Iridium(III) Complexes Incorporating Functionalized 2,2':6',2″ Terpyridines and 2,6-Bis(thiazol-2-yl)pyridines.

A series of iridium(III) triimine complexes incorporating 2,2':6',2″-terpyridine (terpy) and 2,6-bis(thiazol-2-yl)pyridine (dtpy) derivatives were successfully designed and synthesized to investigate the impact of the peripheral rings (pyridine, thiazole) and substituents (thiophene, bithiophene, EDOT) attached to the triimine skeleton on their photophysical properties. The Ir(III) complexes were fully characterized using IR, 1H, elemental analysis and single crystal X-ray analysis. Their thermal properties were evaluated using TGA measurements. Photoluminescence spectra of [IrCl3L1-6] were investigated in solution at 298 and 77 K. The experimental studies were accompanied by DFT/TDDFT calculations. The photophysical properties of the synthesized triimine ligands and Ir(III) complexes were studied in detail by electronic absorption and emission. In solution, they exhibited photoluminescence quantum yields ranging from 1.27% to 5.30% depending on the chemical structure. The experimental research included DFT/TDDFT calculations. The photophysical properties of the synthesized triimine ligands and Ir(III) complexes were conducted using electronic absorption and emission techniques. In solution, they displayed photoluminescence quantum yields ranging from 1.27% to 5.30% depending on the chemical structure.

Scavenger-Based Immobilized Rh and Ir Complexes in Hydrogenation of Propyne and Propene with Parahydrogen

Scavenger-Based Immobilized Rh and Ir Complexes in Hydrogenation of Propyne and Propene with Parahydrogen

High‐Efficiency and Long‐Lifetime Near‐Infrared OLEDs Based on Iridium Complexes with Enhanced Horizontal Emitting Dipole Orientation

AbstractHigh‐efficiency and long‐lifetime near‐infrared (NIR) organic light‐emitting diodes (OLEDs) are rarely reported. Herein, three efficient NIR Ir(III) complexes 1–3 are developed with specially designed cyclometallated ligands based on pyrido[3,4‐b]pyrazine and oriented substitutions along the Ir─N bond axis. Electron‐deficient pyrazine ring effectively stabilizes LUMO energy, leading to significant emission bathochromic shift. Importantly, for complexes 2 and 3, oriented substitutions along the direction of the Ir─N bond axis considerably enhance the horizontal emitting dipole orientation ratio up to 90%. Their OLEDs demonstrate high maximum external quantum efficiencies (EQEs), negligible efficiency roll‐offs, superior radiance, and long lifetimes. The maximum EQEs and radiances of devices are 9.84% and 158 W Sr−1 m−2 at 725 nm for 1, 6.98% and 14.03 W Sr−1 m−2 at 760 nm for 2, and 12.49% and 18.94 W Sr−1 m−2 at 735 nm for 3, respectively. The device lifetime LT97 at 10 mA cm−2 is 453 h for complex 2, which sets a champion lifetime for NIR‐OLEDs. This work demonstrates that pyrido[3,4‐b]pyrazine is a desired building block for robust NIR emitting Ir(III) complexes, providing a superior paradigm to combine high efficiency, negligible roll‐off, and long device lifetime simultaneously toward practical applications.

Facile one-pot synthesis of Ir(III) Bodipy polymeric gemini nanoparticles for tumor selective NIR photoactivated anticancer therapy

Over the last decades, a variety of metal complexes have been developed as chemotherapeutic agents. Despite the promising therapeutic prospects, the vast majority of these compounds suffer from low solubility, poor pharmacological properties, and most importantly poor tumor accumulation. To circumvent these limitations, herein, the incorporation of cytotoxic Ir(III) complexes and a variety of photosensitizers into polymeric gemini nanoparticles that selectively accumulate in the tumorous tissue and could be activated by near-infrared (NIR) light to exert an anticancer effect is reported. Upon exposure to light, the photosensitizer is able to generate singlet oxygen, triggering the rapid dissociation of the nanostructure and the activation of the Ir prodrug, thereby initiating a cascade of mitochondrial targeting and damage that ultimately leads to cell apoptosis. While selectively accumulating into tumorous tissue, the nanoparticles achieve almost complete eradication of the cisplatin-resistant cervical carcinoma tumor in vivo upon exposure to NIR irradiation.

Selective B(3)-H Activation Affording Multinuclear Ir(III) Complexes with (o-Carboranyl)dithioester Ligands.

A method was developed to link two or three o-carborane moieties to form a series of carboranyl dithioester bridging ligands via in situ substitution of haloalkanes by tetraphenylphosphonium carboranyldithiocarboxylates. Based on these ligands, direct B-H activation without the assistance of Ag(I) and alkali was successfully achieved with half-sandwich Ir(III) substrate [Cp*IrCl2]2 to yield corresponding bimetallic or trimetallic complexes. Single crystal structure analyses of the B-H activated complexes and corresponding SnCl2-inserted derivatives confirm the selective B(3)-H activation in these complexes.

Electronic Structure of Metallophlorins: Lessons from Iridium and Gold Phlorin Derivatives.

Phlorins have long remained underexplored relative to their fully conjugated counterparts, such as porphyrins, hydroporphyrins, and corroles. Herein, we have attempted to bridge that knowledge gap with a scalar-relativistic density functional theory (DFT) study of unsubstituted iridium and gold phlorin derivatives and a multitechnique experimental study of iridium-bispyridine and gold complexes of 5,5-dimethyl-10,15,20-tris(pentafluorophenyl)phlorin. Theory and experiments concur that the phlorin derivatives exhibit substantially smaller HOMO-LUMO gaps, as reflected in a variety of observable properties. Thus, the experimentally studied Ir and Au complexes absorb strongly in the near-infrared (NIR), with absorption maxima at 806 and 770 nm, respectively. The two complexes are also weakly phosphorescent with emission maxima at 950 and 967 nm, respectively. They were also found to photosensitize singlet oxygen formation, with quantum yields of 40 and 28%, respectively. The near-infrared (NIR) absorption and emission are consonants with smaller electrochemical HOMO-LUMO gaps of ∼1.6 V, compared to values of ∼2.1 V, for electronically innocent porphyrins and corroles. Interestingly, both the first oxidation and reduction potentials of the Ir complex are some 600 mV shifted to more negative potentials relative to those of the Au complex, indicating an exceptionally electron-rich macrocycle in the case of the Ir complex.

Tuning Excited State Character in Iridium(III) Photosensitizers and Its Influence on TTA-UC.

A series of mixed ligand, photoluminescent organometallic Ir(III) complexes have been synthesized to incorporate substituted 2-phenyl-1H-naphtho[2,3-d]imidazole cyclometalating ligands. The structures of three example complexes were categorically confirmed using X-ray crystallography each sharing very similar structural traits including evidence of interligand hydrogen bond contacts that account for the shielding effects observed in the 1H NMR spectra. The structural iterations of the cyclometalated ligand provide tuning of the principal electronic transitions that determine the visible absorption and emission properties of the complexes: emission can be tuned in the visible region between 550 and 610 nm and with triplet lifetimes up to 10 μs. The nature of the emitting state varies across the series of complexes, with different admixtures of ligand-centered and metal-to-ligand charge transfer triplet levels evident. Finally, the use of the complexes as photosensitizers in triplet-triplet annihilation energy upconversion (TTA-UC) was investigated in the solution state. The study showed that the complexes possessing the longest triplet lifetimes showed good viability as photosensitizers in TTA-UC. Therefore, the use of an electron-withdrawing group on the 2-phenyl-1H-naphtho[2,3-d]imidazole ligand framework can be used to rationally promote TTA-UC using this class of complex.

2‐Thiophenyl–Isoquinoline Ir(III) Complex: A Promising Tool in Antipseudomonal Photodynamic Therapy under Red Irradiation

AbstractInnovative therapeutic strategies are more than ever needed to counter the rise of antibiotic–resistant bacterial pathogens worldwide. The use of light, and especially photodynamic therapy (PDT) appears as a promising alternative or complement to antibiotic treatments, fostered by the development of new photosensitizers. In this study, eight Ir(III) complexes were synthesized and evaluated for their photoactivation properties and capacity to generate radical species under blue (452 nm), green (525 nm), and red (631 nm) LED light, respectively. Their antibacterial properties were assessed on Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Staphylococcus aureus with most of these complexes exhibiting potentially useful activities upon light irradiation, at concentrations below 10 mg/L. A complex of Ir(III) cyclometallated to thiophenyl–isoquinoline (tiq) and bearing 2,2’‐bipyridine (bipy) as ancillary ligand was further investigated. This latter showed a concentration‐ and light intensity–dependent bactericidal activity on P. aeruginosa when irradiated under blue to red lights, proving that such complexes would be suitable candidates for PDT. Importantly, this lead complex remained active against antibiotic resistant clinical strains and was unaffected by active efflux systems. These data open interesting perspectives for the development of new treatments to tackle antibiotic resistant Gram–negative bacteria.

Ir(III) Metal Emitters with Cyano-Modified Imidazo[4,5-b]pyridin-2-ylidene Chelates for Deep-Blue Organic Light-Emitting Diodes.

Ir(III) carbene complexes have been explored as one of the best blue phosphors for their high performance. Herein, the authors designed and synthesized a series of blue-emitting Ir(III) phosphors (f-ct9a-c), featuring fac-coordinated cyano-imidazo[4,5-b]pyridin-2-ylidene cyclometalates. These Ir(III) complexes exhibit true-blue emission with a peak maximum spanning 448-467 nm, with high photoluminescence quantum yields of 81-88% recorded in degassed toluene. Moreover, OLED devices bearing phosphors f-ct9a and f-ct9b deliver maximum external quantum efficiencies (EQEmax) of 25.9% and 30.3%, together with Commission Internationale de L'Eclairage (CIEx,y) coordinates of (0.157, 0.225) and (0.142, 0.169), respectively. Remarkably, the f-ct9b-based device displays an incredible EQE of 29.0% at 5000 cd·m-2. The hyper-OLED device based on f-ct9b and ν-DABNA exhibits an EQEmax of 34.7% and CIEx,y coordinates of (0.122, 0.131), affirming high potentials in achieving efficient blue electroluminescence.

Bis-cyclometalated Ir(III) complexes with carbazole/triphenylamine donor fragment for oxygen sensing

Bis-cyclometalated Ir(III) complexes with carbazole/triphenylamine donor fragment for oxygen sensing

An iridium‐based phosphorescence probe for HClO/ClO− detection and application of recognizing exogenous/endogenous HClO/ClO− in cells

Hypochlorous acid (HClO) and its ionic form (ClO−), as important components of reactive oxygen species, were produced mainly in mitochondria and participated in various biological processes, and they abnormal level could cause various diseases and threaten human health. Hence, a “turn‐on” phosphorescent probe Ir‐DAMN based on Ir (III) complex was synthesized to monitor HClO/ClO− in DMF/PBS solution and living cells. Due to isomerization of C=N bond, probe Ir‐DAMN exhibited very weak phosphorescence initially, which displayed obvious phosphorescent enhancement at 620 nm after upon addition with ClO−. Confocal bioimaging experiments implied that probe Ir‐DAMN possessed good cell membrane permeability, specific localization of mitochondria and could achieve detection of exogenous and endogenous HClO/ClO− in the living cells.

Optoelectronic properties and charge transfer dynamics in graphene quantum dot/Ir(III) nanocomposites: Enhancing photocatalytic performance through strategic BTF conjugate binding and end-capping variations

The aim of this study is to analyze the optoelectronic properties and charge transfer kinetics in nanocomposites comprising graphene quantum dots (GQDs) and Ir(III) complexes, with a specific focus on their relevance in photocatalytic applications. The investigation explores how the extent of π-conjugation, variations in end-capping substituents, and the binding position of benzothiazole fluorene (BTF) conjugates influence the electronic structures. The results indicate that attaching GQDs alters the band gaps and results in different energy alignments. By adjusting the position of BTF conjugate binding and the end-capping substituent, optimal photocatalytic performance can be achieved. Binding the BTF conjugate at the para-position enhances electron injection into TiO2, thereby improving photocatalysis. Conversely, binding the BTF at the meta-position contributes to the regeneration of the ground state, leading to increased light absorption and photoelectric conversion. Furthermore, incorporating a BTF conjugate at the meta-position of the 2-phenyl pyridine ligand enhances light absorption and photoelectric conversion in the nanocomposites. These findings pave the way for further exploration of the effects of different conjugate binding positions and substituents on the overall properties and potential applications of these nanocomposites.

Development of Half-Sandwich Ru, Os, Rh, and Ir Complexes Bearing the Pyridine-2-ylmethanimine Bidentate Ligand Derived from 7-Chloroquinazolin-4(3H)-one with Enhanced Antiproliferative Activity.

Kinesin spindle protein (KSP) inhibitors are one of the most promising anticancer agents developed in recent years. Herein, we report the synthesis of ispinesib-core pyridine derivative conjugates, which are potent KSP inhibitors, with half-sandwich complexes of ruthenium, osmium, rhodium, and iridium. Conjugation of 7-chloroquinazolin-4(3H)-one with the pyridine-2-ylmethylimine group and the organometallic moiety resulted in up to a 36-fold increased cytotoxicity with IC50 values in the micromolar and nanomolar range also toward drug-resistant cells. All studied conjugates increased the percentage of cells in the G2/M phase, simultaneously decreasing the number of cells in the G1/G0 phase, suggesting mitotic arrest. Additionally, ruthenium derivatives were able to generate reactive oxygen species (ROS); however, no significant influence of the organometallic moiety on KSP inhibition was observed, which suggests that conjugation of a KSP inhibitor with the organometallic moiety modulates its mechanism of action.